Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global $51.3 Bn Women's Health Market Analysis 2014-2017 & 2025

Research and Markets
Posted on: 27 Nov 17
Global $51.3 Bn Women's Health Market Analysis 2014-2017 & 2025

PR Newswire

DUBLIN, November 27, 2017

DUBLIN, November 27, 2017 /PRNewswire/ --

The "Women's Health Market Analysis By Application (Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome), By Region, And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

The global women's health market is expected to reach USD 51.3 billion by 2025

Further Key Findings From the Report Suggest:

  • Presence of a large female geriatric population, which is susceptible to chronic diseases, is expected to boost growth
  • In 2016, postmenopausal osteoporosis accounted for the largest share of the market due to high incidence of osteoporosis in women after menopause, presence of several major players, and cost-effectiveness of this treatment
  • Contraceptive segment is likely to witness fastest growth during the forecast period due to increase in awareness and usage, government initiatives, technological developments, and favorable regulatory scenario. For instance, in June 2017, Agile Therapeutics, Inc. resubmitted an NDA for Twirla, an investigational low-dose combined hormonal contraceptive patch
  • Geographically, North America held the largest share of more than 30% in 2016 due to presence of major market players, high awareness about regular health check-ups for women, coverage for screening, and increased healthcare expenditure
  • Asia Pacific is expected to exhibit fastest growth during the forecast period due to increasing investments by players in the region, rising awareness about women's health, and initiatives by various governments and private organizations to improve awareness and access to women's health products
  • Some of the key players operating in the women's health market are Allergan; Bayer AG; Merck & Co., Inc.; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.; Agile Therapeutics; Amgen, Inc.; AstraZeneca; Bristol-Myers Squibb Company; and Ferring B.V.

Increasing female geriatric population, introduction of various drugs related to women's health, and favorable government policies are some of the factors expected to drive growth during the forecast period.

Women are more prone to certain diseases, such as osteoporosis, osteoarthritis, anemia, menstruation-related disorders, depression, and obesity. Hence, increase in incidence of these conditions is likely to boost the market in the coming years. According to International Osteoporosis Foundation, global prevalence of osteoporosis among women was over 200.0 million in 1990, and this is anticipated to reach 680.0 million in 2050.

Government and various private organizations are working toward improving women's health across the world, and this is likely to drive growth in the coming years. Reimbursement coverage provided to women is also a key factor driving the market in developed countries. For instance, various coverage plans in the U.S. provide preventive services for women without charging any copayment. These include screening for anemia, hepatitis B, & breast cancer on a routine basis, folic acid supplements for women who are likely to be pregnant, and contraceptive methods, among others.

Key Topics Covered:

Chapter 1. Research Methodology

Chapter 2. Executive Summary

Chapter 3. Women's Health Market Variables, Trends & Scope

Chapter 4. Women's Health Market: Drug Estimates & Trend Analysis

Chapter 5. Women's Health Market: Application Estimates & Trend Analysis

Chapter 6. Women's Health Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

  • Allergan
  • Bayer AG
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Agile Therapeutics
  • Amgen, Inc.
  • Apothecus Pharmaceutical Corporation
  • AstraZeneca
  • Blairex Laboratories, Inc.
  • Bristol-Myers Squibb Company
  • Ferring B.V.

For more information about this report visit https://www.researchandmarkets.com/research/57k866/womens_health

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-513-bn-womens-health-market-analysis-2014-2017--2025-300561846.html

SOURCE Research and Markets

PR Newswire
www.prnewswire.com

Last updated on: 27/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.